Peter Chatfield
Impact in
-
- PARP inhibition in cancer therapy
- Bone health and treatments
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 6
- Prostate Cancer Diagnosis and Treatment 1
- Oncology 4
- PARP inhibition in cancer therapy 3
- Bone health and treatments 1
- Co-authors
- Emma Hall (5 shared papers)Robert J. Jones (1 shared paper)Johann S. de Bono (2 shared papers)Simon J. Crabb (1 shared paper)Omi Parikh (1 shared paper)Cláudia Bertan (1 shared paper)Tony Elliott (1 shared paper)Diletta Bianchini (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Therapeutic Advances in Medical Oncology (1 paper)Clinical Genitourinary Cancer (1 paper)Annals of Oncology (1 paper)JNCI Cancer Spectrum (1 paper)
- Partner nations
- United KingdomNew ZealandBrazil
In The Last Decade
Peter Chatfield
7 papers receiving 59 citations
Peers
Comparison fields: 5 of 22
- Oncology 41
- Pulmonary and Respiratory Medicine 40
- Radiology, Nuclear Medicine and Imaging 14
- Aging 1
- Cancer Research 8
Countries citing papers authored by Peter Chatfield
This map shows the geographic impact of Peter Chatfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Chatfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Chatfield more than expected).
Fields of papers citing papers by Peter Chatfield
This network shows the impact of papers produced by Peter Chatfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Chatfield. The network helps show where Peter Chatfield may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Chatfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 36 | |
| 2 | 2021 | 9 | |
| 3 | 2020 | 5 | |
| 4 | 2023 | 3 | |
| 5 | 2016 | 2 | |
| 6 | 2019 | 2 | |
| 7 | 2018 | 2 |
About Peter Chatfield
Peter Chatfield is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Reproductive Medicine and Cancer Research, having authored 7 papers that have together received 59 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), PARP inhibition in cancer therapy (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Medical Imaging Techniques and Applications (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Cancer Genomics and Diagnostics (1 paper), Prostate Cancer Diagnosis and Treatment (1 paper) and Bone health and treatments (1 paper). The work is most often cited by research in Oncology (41 citations), Pulmonary and Respiratory Medicine (40 citations), Radiology, Nuclear Medicine and Imaging (14 citations), Aging (1 citation) and Cancer Research (8 citations). Peter Chatfield has collaborated with scholars based in United Kingdom, New Zealand and Brazil. Frequent co-authors include Emma Hall, Robert J. Jones, Johann S. de Bono, Simon J. Crabb, Omi Parikh, Cláudia Bertan, Tony Elliott, Diletta Bianchini, Suneil Jain and Mohini Varughese. Their work appears in journals such as Journal of Clinical Oncology, Therapeutic Advances in Medical Oncology, Clinical Genitourinary Cancer, Annals of Oncology and JNCI Cancer Spectrum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.